Equities

Mushrooms Inc

MSRM:PKC

Mushrooms Inc

Actions
  • Price (USD)0.012
  • Today's Change0.001 / 9.00%
  • Shares traded8.10k
  • 1 Year change-78.38%
  • Beta0.5784
Data delayed at least 15 minutes, as of Nov 22 2024 17:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mushrooms, Inc. is focused on the industrial application of mycelium for the creation of carbon-neutral products for the building and health care industries, as well as creating supplements based on the proven health benefits of mushrooms. The Company’s research and development is focused on bringing the science of mycology to the forefront of manufacturing by replacing toxic plastics, packaging, and improving medical threads and fabrics. Mycelium is a natural fiber, which is used as an alternative to plastics. The mycelium can be used in applications such as insulation, structural insulating panels, acoustical tiles, and building blocks. It is improving the threads and fabrics in use with its antimicrobial, anti-MRSA, renewable and eco-positive threads and fabric solutions. It also works together with scientists and medical supply innovators to implement this technology into the range of potential medical applications.

  • Revenue in USD (TTM)47.99k
  • Net income in USD-132.43k
  • Incorporated2002
  • Employees34.00
  • Location
    Mushrooms Inc23150 Fashion Drive, Suite 231ESTERO 33928United StatesUSA
  • Phone+1 (406) 873-5580
  • Fax+1 (406) 873-2835
  • Websitehttps://www.mushroomsinc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sharing Services Global Corp9.90m-4.27m108.38k32.00------0.011-15.91-15.9136.72-13.611.341.8027.14309,300.00-57.81-50.60---575.0763.4469.87-43.11-23.270.29-6.76-----32.44-33.8682.19------
Better for You Wellness Inc18.20k-1.79m253.90k4.00------13.95-0.0041-0.00410.00004-0.0050.03550.45683.464,550.00-349.59------28.46---9,846.98--0.0093-4.19-----9.55--30.43------
Mushrooms Inc47.99k-132.43k433.79k34.00--0.0004--9.04-7.27-7.272.6425.390.0876--6.39---24.18-23.32-25.60-24.1035.40---275.95-192.18----0.00--63.74-20.74-36.67------
Ecomax Inc799.16k-51.60k480.95k24.00------0.6018-0.0217-0.02170.3357-0.14267.4712.9513.11---48.26-537.02----25.58---6.46-106.620.092-0.7022--------21.54------
Nowfinance Inc4.08m-2.10m762.98k25.00------0.1871-0.224-0.2240.4345-1.060.840316.48--163,089.60-43.32------63.37---51.55--0.3264-0.80123.26---5.64--15.09------
Global Roundtable Corp3.55m1.78m1.08m20.000.042--4.190.30520.00360.00360.00740.03320.3053--768.00--15.28-105.4320.12-375.9666.6679.2950.05-2,205.90----0.0691------438.46------
Right On Brands Inc1.40m-411.63k2.08m2.00------1.48-0.0162-0.01620.0559-0.03167.076.12-----207.37-433.00----57.1742.03-29.33-417.120.0742-0.2224----13.92161.22103.40------
Data as of Nov 22 2024. Currency figures normalised to Mushrooms Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.